2.99
-0.0299(-0.99%)
Currency In USD
| Previous Close | 3.02 |
| Open | 2.93 |
| Day High | 3.06 |
| Day Low | 2.61 |
| 52-Week High | 10.66 |
| 52-Week Low | 1.72 |
| Volume | 43,702 |
| Average Volume | 377,401 |
| Market Cap | 6.68M |
| PE | -0.4 |
| EPS | -7.39 |
| Moving Average 50 Days | 2.84 |
| Moving Average 200 Days | 2.97 |
| Change | -0.03 |
If you invested $1000 in GT Biopharma, Inc. (GTBP) since IPO date, it would be worth $3.53 as of December 30, 2024 at a share price of $2.99. Whereas If you bought $1000 worth of GT Biopharma, Inc. (GTBP) shares 5 years ago, it would be worth $59.83 as of December 30, 2024 at a share price of $2.99.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
GlobeNewswire Inc.
Sep 26, 2024 1:15 PM GMT
SAN FRANCISCO, CALIFORNIA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural kille
GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024
GlobeNewswire Inc.
Sep 24, 2024 1:15 PM GMT
SAN FRANCISCO, CALIFORNIA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural kille